Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

At first, he dismissed it as a possible sinus infection, but after a series of medical tests, a neuro-ophthalmologist diagnosed him with non-arteritic anterior ischemic optic neuropathy (NAION ...

Semaglutide was tied to nonarteritic anterior ischemic optic neuropathy (NAION) risk vs. nonuse in adults with type 2 diabetes. New semaglutide users did not have higher NAION risk vs. most other ...

People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition that affects the optic nerve, a new study says. Patients on ...

Non-arteritic anterior ischemic optic neuropathy (NAION) - also known as a "eye stroke" - typically causes sudden vision loss in one eye. It occurs from a lack of sufficient blood flow to the ...

Optic Neuritis: Clinical Features Optic neuritis refers to inflammation of the optic nerve. The term may be used broadly in reference to many causes of optic nerve inflammation including systemic ...

Patients on semaglutide (Ozempic, Wegovy) had a 32% increased relative risk of developing nonarteritic anterior ischemic optic neuropathy (NAION) compared to people not taking the drug ...

Is It A Rare And Serious Condition? NAION is a condition that results in sudden, painless loss of vision due to reduced blood flow to the optic nerve head (ONH). It is the most common cause of ...